Make Money Online with Honeygain! - Download this free software for your Windows computer, Android or iOS phone and get paid to share your internet connection! Download, turn it on and earn!

Demand for Hospital Acquired Infections (HAI) Diagnostics and Impact of COVID-19

Posted by mrudulaGVR on May 4th, 2020

Global hospital acquired infections diagnostics market is expected to reach USD 11.6 billion by 2022, according to a new report by Grand View Research, Inc. A surge in hospital traffic due to admissions for Covid-19 cases has increased the burden of hospital-acquired infections. The overpopulation of major healthcare infrastructure due to the Covid-19 pandemic is a key aspect taken into account while updating the market model for this report.

Some major players actively involved in the industry are bioMérieux, Abbott Laboratories, Roche AG, and Siemens Healthcare among others. In an attempt to ensure sustainability and register growth, the companies adopted several strategies such as partnerships, joint ventures, new product developments, collaborations, and acquisitions.

The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR during the period of 2015 to 2022. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/hospital-acquired-infections-hai-diagnostics-market/request/rs2

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2015 to 2022.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Further key findings from the study suggest:

  • In the year 2015, North America held the largest share in the industry in terms of value. The rising awareness of HAI, application of technologically advanced products, and significant measures taken by the government to counter HAIs are some of the major factors contributing to industry growth.
  • The AsiaPacific is projected to witnessthe highest growth in the coming years, as incidence of HAIs is on rise in the region. This market is projected to grow rapidly at the highest CAGR of around 20% during the period 2015 to 2022.
  • As of 2015, the diagnostic market for UTI acquired in hospitals led the industry at a global level. On the other hand, the pneumonia segment is expected to witness the highest growth over the forecast period.
  • The industry constitutes of numerous local and global players. Some key players of this market include bioMérieux, Abbott Laboratories, Roche AG, and Siemens Healthcare among others. 

The global Hospital Acquired Infection (HAI) diagnostic market size was estimated to be USD 3.6 billion in 2015. HAIs have been of increasing concern in healthcare facilities across the globe. According to the WHO, among hundred patients in hospitals, ten patients are estimated to suffer from HAIs in developing countries, and seven in developed countries.

In developed countries, after cancer and cardiovascular diseases, HAI is considered to be the third leading reason for mortality. In the U.S. and European regions, six million patients are affected every year, resulting in around150,000 deaths.

The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.

Other aspects supporting industry growth are growing demand of HAI diagnostics from middle and low-income countries such as India and Brazil, development of technologically advanced diagnostic products, rising awareness among healthcare workers, and initiatives taken by governments to counter the prevalence of HAIs.
However, decreasing prevalence of nosocomial infections in the developed countries owing to improved healthcare infrastructure and rising awareness are expected to restrict industry growth.

The HAI diagnostic market is broadly classified into Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Surgical Site Infections (SSI), pneumonia/lower respiratory infections, and others such as cardiovascular and gastro intestinal infections. The UTI diagnostics market is expected to lead the market with the largest share in the year 2015, whereas the industry for diagnosis of pneumonia as a nosocomial infection is anticipated to witness the highest growth in the industry during the forecast period.

Grand View Research has segmented the global hospital acquired infections diagnostic market on the basis of infection type, test type:

Hospital Acquired Infections Diagnostic Infection Type Outlook (Revenue, USD Million, 2012 - 2022)

  • Bloodstream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Surgical Site Infections (SSI)
  • Pneumonia
  • Others

Hospital Acquired Infections Diagnostic Test Type Outlook (Revenue, USD Million, 2012 - 2022)

  • Molecular Diagnostics Tests
  • Other In-vitro Diagnostic Tests

On the basis of types of tests, the industry is segmented into molecular diagnostics and other IVD tests including urinalysis and blood tests. The molecular diagnostics segment is projected to grow at the highest CAGR during the period of 2015 to 2022. Rapid results with less turnaround time, high sensitivity, and accuracy are some of the factors attributing to industry growth in the near future.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Also See: Hospital Acquired, Acquired Infections, Industry Growth, Hai Diagnostics, Market, Infections, Infection

How To Draw A Car Fast & Easy
Learn how to draw a car using our step by step tutorials. Sports cars, classic cars, imaginary cars - we will show you how to draw them like the pros.
CryptoTab Browser - Easy way for Bitcoin Mining | CryptoTab Browser
CryptoTab Browser is the world's first web browser with built-in mining features. Familiar Chrome user interface is perfectly combined with extremely fast mining speed. Mine and browse at the same time!

Lolli: Earn Free Bitcoin When You Shop Online!
Lolli is a rewards application that gives you bitcoin for shopping at your favorite online stores.

Share Your Internet Connection & Get Paid
HoneyGain is compatible for desktop computers, Android and iOS and pays you when you share your internet connection!

Advertise Here